Trials / Conditions / Chronic HCV Infection

Chronic HCV Infection

14 registered clinical trials studyying Chronic HCV Infection.

Status	Trial	Sponsor	Phase
Completed	Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatit NCT05395416	Sunshine Lake Pharma Co., Ltd.	Phase 2 / Phase 3
Completed	Phase 3 Study of Yimitasvir Phosphate Capsules NCT03487107	Sunshine Lake Pharma Co., Ltd.	Phase 3
Unknown	Clinical Pharmacokinetics of Daclatasvir/Sofosbuvir in Adolescents With Hepatitis C Virus NCT03540212	Ain Shams University	Phase 2 / Phase 3
Completed	Phase 2 Study of Yimitasvir Phosphate Capsules NCT03458481	Sunshine Lake Pharma Co., Ltd.	Phase 2
Completed	Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïv NCT02973503	University Hospital, Clermont-Ferrand	Phase 3
Completed	Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects Wi NCT02120300	Gilead Sciences	Phase 2
Completed	Safety and Efficacy of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Chronic Genotype 1 or 3 HCV In NCT02074514	Gilead Sciences	Phase 3
Completed	Ledipasvir/Sofosbuvir Fixed-Dose Combination Plus Ribavirin in Participants With Chronic HCV With Advanced Liv NCT02010255	Gilead Sciences	Phase 2
Completed	Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV Infection NCT02021643	Gilead Sciences	Phase 3
Completed	Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Participants With Chronic Genotype 1 HC NCT02021656	Gilead Sciences	Phase 3
Completed	Efficacy and Safety of Sofosbuvir/Ledipasvir ± Ribavirin in Japanese Participants With Chronic Genotype 1 HCV NCT01975675	Gilead Sciences	Phase 3
Completed	Ledipasvir/Sofosbuvir Fixed-Dose Combination With Ribavirin or GS-9669 in Subjects With Chronic Genotype 1 HCV NCT01984294	Gilead Sciences	Phase 2
Completed	Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Dise NCT01938430	Gilead Sciences	Phase 2
Unknown	Role of Heme Oxygenase in the Pathogenesis of Hepatocellular Injury in Chronic Hepatitis C Virus (HCV) Infecti NCT00842205	Charles University, Czech Republic	N/A